Evidence map›Paper›PMID 41107564›Full record

ReviewJournal of hematopathology2025

Practical diagnostic approach to assess myeloid and precursor cell neoplasms on trephine bone marrow biopsies: reflection of middle European reality.

Thomas Menter, Alexandar Tzankov

Abstract readReview
In one paragraph

Review in Journal of hematopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thomas MenterInstitute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Schönbeinstrasse 40, Basel, Switzerland.
Alexandar TzankovInstitute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Schönbeinstrasse 40, Basel, Switzerland. alexandar.tzankov@usb.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trephine bone marrow biopsies (TBMB) are standard specimens for diagnostics and follow-up of myeloid and precursor cell neoplasms, usually as part of a multimodal approach including complete blood count (CBC) tests, cytologic assessment of BM aspirate smears, flow cytometry, cytogenomics, and molecular genetics. Incorporating the results of all the above methods or running all tests within one specialized lab and providing an integrative report is ideally desirable. However, in reality, in many countries, (1) diagnostic (hemato-)pathologists may not have access to information on the results obtained by other technologies except for a CBC, (2) individual procedures may not be available at all, (3) specimens may not be submitted to specialized labs, or (4) particular technologies may fail yielding results (e.g., dry taps or specimens with destroyed nucleic acids), so that the TBMB might remain the only analytic sample. The detailed description of our approach to handling TBMB including classic histopathology, immunohistochemistry, fluorescence in situ hybridization, and sequencing techniques in the setting of myeloid and precursor neoplasms may help the readership to achieve a comprehensive TBMB diagnostic approach reaching more definite and robust conclusions to improve patient care.

Indexed as

Bone MarrowMyeloproliferative DisordersBiopsyEuropeHumansALLAMLBPDCNHistopathologyMDSMDS/MPNMPNSystemic mastocytosisTrephine bone marrow biopsy

Identifiers

PMID41107564
PMCPMC12534240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.